Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 5
Submit an article Journal homepage
921
Views
21
CrossRef citations to date
0
Altmetric
Author's View

The mutually regulatory loop of epithelial–mesenchymal transition and immunosuppression in cancer progression

Limo ChenDepartment of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TXUSA
,
John V HeymachDepartment of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TXUSA
,
F Xiao-Feng QinDepartment of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TXUSA;Center of Systems Medicine, Institute of Basic Medical Sciences, Suzhou, China;Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaCorrespondence[email protected] [email protected]
&
Don L GibbonsDepartment of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TXUSA;Department of Molecular and Cellular Oncology; The University of Texas MD Anderson Cancer Center; Houston, TXUSACorrespondence[email protected] [email protected]
Article: e1002731 | Received 19 Dec 2014, Accepted 23 Dec 2014, Published online: 21 May 2015

References

  • Radvanyi L. Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality. Mol Ther 2013; 21:1472–4; PMID:23903573; http://dx.doi.org/10.1038/mt.2013.160
  • Shintani Y, Okimura A, Sato K, Nakagiri T, Kadota Y, Inoue M, Sawabata N, Minami M, Ikeda N, Kawahara K, et al. Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg 2011; 92:1794–804; discussion 1804; PMID:22051275; http://dx.doi.org/10.1016/j.athoracsur.2011.07.032
  • Li T, Zeng ZC, Wang L, Qiu SJ, Zhou JW, Zhi XT, Yu HH, Tang ZY. Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition. Cancer Gene Ther 2011; 18:617–26; PMID:21637307; http://dx.doi.org/10.1038/cgt.2011.29
  • Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn YH, Byers LA, Zhang X, Yi X, Dwyer D, Lin W, et al. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun 2014; 5:5241; PMID:25348003; http://dx.doi.org/10.1038/ncomms6241.
  • Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 2009; 23:2140–51; PMID:19759262; http://dx.doi.org/10.1101/gad.1820209
  • Patnaik SK, Kannisto E, Knudsen S, Yendamuri S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 2010; 70:36–45; PMID:20028859; http://dx.doi.org/10.1158/0008-5472.CAN-09-3153
  • Reiman JM, Knutson KL, Radisky DC. Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells. Cancer Res 2010; 70:3005–8; PMID:20395197; http://dx.doi.org/10.1158/0008-5472.CAN-09-4041.
  • Toh B, Wang X, Keeble J, Sim WJ, Khoo K, Wong WC, Kato M, Prevost-Blondel A, Thiery JP, Abastado JP. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 2011; 9:e1001162; PMID:21980263; http://dx.doi.org/10.1371/journal.pbio.1001162
  • Liu CY, Xu JY, Shi XY, Huang W, Ruan TY, Xie P, Ding JL. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest 2013; 93:844–54; PMID:23752129; http://dx.doi.org/10.1038/labinvest.2013.69.
  • Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol 2012; 8:713–22; PMID:22764769; http://dx.doi.org/10.2217/fon.12.59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.